Overview

Rd2 or retinal degeneration slow (rds) is a dominant spontaneous mutation in Prph2 (peripherin 2), mutant mice are characterized by slow degeneration of the outer nuclear layer of the retina beginning at 5 weeks, and eventual loss of retinal rod and cone cells by 12 months of age. This strain may be useful for studying human retinopathies.

Genetic overview

Genetic Background	Generation
	N20F90 (2016-12-29 00:00:00)

Prph2^Rd2

Allele Type	Gene Symbol	Gene Name
Spontaneous	Prph2	peripherin 2

Pde6b⁺

Allele Type	Gene Symbol	Gene Name
Not Applicable	Pde6b	phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide

View Genetics

Research Applications

Research Tools
Mouse/Human Gene Homologs
Sensorineural Research

View All Research Applications

Base Price

Starting at:

$135.09 Domestic price for female

View Price List

Details

Detailed Description

Prph2 (peripherin 2) encodes a tetraspanning membrane protein found in the outer segment of both rod and cone photoreceptor cells, which is involved in photoreceptor disc morphogenesis. In this congenic strain, the retinal degeneration 2 (Prph2^Rd2) allele was transferred from strain O20/A to C3A.BLiA-Pde6b⁺ (wild-type for retinal degeneration 1 - rd1).
Rd2 or retinal degeneration slow (rds) is a dominant spontaneous mutation characterized by slow degeneration of the outer nuclear layer of the retina beginning at 5 weeks, loss of retinal rod cells by 7-10 months, loss of cone cells and all visual cell structures by 12 months of age, loss of some pigment epithelial cells and increased density of Muller cells accompanied by fibrillary tangles. This strain may be useful for studying human retinopathies.

Development

This strain was developed in the laboratory of Dr. Willem J. De Grit at Erasmus Universiteit, Rotterdam, the Netherlands. The Prph2^Rd2 allele was transferred from strain O20/A to C3A.BLiA-Pde6b⁺ via more than 20 backcross-intercross cycles (Schalken et al. 1990; S. Sanyal, personal communication). C3A.BLiA-Pde6b⁺ is a congenic strain having the wildtype Pde6b allele of C57BL/LiA on the C3Hf/HeA background. Since its arrival at The Jackson Laboratory, Stock No. 001979 has been maintained by sibling mating of mice homozygous for both Pde6b⁺ and Prph2^Rd2.

Expression Data

Expressed Gene	Pde6b, phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide, mouse, laboratory
Site of Expression	Retina.

Control Suggestions

001912 C3A.BLiA-Pde6b⁺/J

Additional Information

Considerations for Choosing Controls

Selected References

Schalken JJ; Janssen JJ; Sanyal S; Hawkins RK; de Grip WJ. 1990. Development and degeneration of retina in rds mutant mice: immunoassay of the rod visual pigment rhodopsin. Biochim Biophys Acta 1033(1):103-9PubMed: 2137350 MGI: J:109932

View All References

Genetics

Prph2^Rd2

Allele Symbol: Prph2^Rd2

Allele Name	retinal degeneration 2
Allele Type	Spontaneous
Allele Synonym(s)	retinal degeneration 2; Prph2^Rd2
Gene Symbol and Name	Prph2, peripherin 2
Gene Synonym(s)	AVMD; AOFMD; Rd-2; Rd2; Rds; Nmf193; RDS; CACD2; RSRDS; Rd2; Nmf193; DS; retinal degeneration 2; retinal degeneration, slow; retinal degeneration, slow (retinitis pigmentosa 7); TSPAN22; PRPH; neuroscience mutagenesis facility, 193; RP7; MDBS1; rds; Tspan22; rds; Rds; rd2
Strain of Origin	O20/A
Chromosome	17
Molecular Note	The mutation is an insertion of approximately 10 kb in the gene after nucleotide 899 (numbering of the encoded mRNA), disrupting the protein coding sequence in exon 2. The inserted DNA was similar to both the TSE of mice, repeated elements found in the H2 complex, and to the mouse early transposon (ETn). Northern blot analysis demonstrated that an aberrant 12 kb transcript was produced from this allele, although at reduced levels compared to wild-type. This allele is predicted to encode a truncated protein with its carboxy terminal 116 amino acids replaced by 35 amino acids from sequences in the insertion. Mutant mice doubly homozygous for two retinal degeneration mutations (Pde6b^rd1 and Rds^Rd2) shows an intermediate level of mRNAs for the beta subunit of cGMP-PDE and for several other phototransduction related proteins, suggesting an interaction between Pde6b^rd1 and Rds^Rd2.

Pde6b⁺

Allele Symbol: Pde6b⁺

Allele Name	wild type
Allele Type	Not Applicable
Allele Synonym(s)	Pde6b⁺; wild type
Gene Symbol and Name	Pde6b, phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide
Gene Synonym(s)	rd; rd1; Pdeb; r; rd; rd10; nmf137; r; retinal degeneration; retinal degeneration 1; retinal degeneration 10; CSNB3; CSNBAD2; rd1; rd-1; rd10; PDEB; RP40; phosphodiesterase, cGMP, rod receptor, beta polypeptide; Pdeb; GMP-PDEbeta
Expressed Gene	Pde6b, phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide, mouse, laboratory
Site of Expression	Retina.
Strain of Origin	Not Applicable
Chromosome	5

Disease/Phenotype

Disease Terms

Model with phenotypic similarity to human disease where etiologies involve orthologs. Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).

retinitis pigmentosa 7

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Genotype: Prph2^Rd2 related

Research Tools
- Sensorineural Research
  - retinal degeneration
Sensorineural Research
- Retinal Degeneration
Mouse/Human Gene Homologs
- retinal degeneration, slow

Genotype: Pde6b⁺ related

Mouse/Human Gene Homologs
- retinitis pigmentosa, wildtype
Sensorineural Research
- Retinal Degeneration
  - wild-type

Mammalian Phenotype Terms by Genotype

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: Prph2^Rd2/Prph2^Rd2
O20/A-Prph2

cardiovascular system phenotype

retinal neovascularization
- extensive vascularization at 12 months of age

pigmentation phenotype

abnormal retinal pigment epithelium morphology
- at 12 months of age the pigment epithelium appears patchy with normal appearing areas adjacent to areas lacking pigment epithelial cells
- phagosomes containing debris from the outer nuclear layer are absent

hematopoietic system phenotype

abnormal macrophage morphology
- as the outer nuclear layer thins, fewer macrophages are detected in this layer of the retina
- at 12 months of age only a few small macrophages remain in the outer aspect of the inner nuclear layer
- at P11 macrophages in the retina remain large and display high levels of glucosaminidase activity

vision/eye phenotype

abnormal eye electrophysiology
- absence of detectable a-wave at all intensities tested at 6-7 and 13 months of age
- b-wave amplitudes are reduced but still detectable at higher intensities at 6-7 months of age
- smaller a-wave and b-wave amplitudes at all intensities tested at 1 and 2-3 months of age compared to age matched controls
- time to peak of the waves is increased at 2-3 months of age but not at 1 month of age compared to age matched controls

abnormal retina morphology
- thin with distorted structure at 12 months of age

abnormal retinal cone cell morphology
- at 2 months of age the percentage of cones is higher in the periphery compared to wild-type controls
- the percentage of cones in the periphery further increases up until 6 months of age

abnormal retinal development
- decrease in growth of retinal thickness from P7 onwards
- morphological differences from controls are clearly recognizable by P14

abnormal retinal neuronal layer morphology
- at 9 months of age in some areas the outermost row of the inner nuclear layer has merged with the outer nuclear layer

abnormal retinal outer nuclear layer morphology
- at 9 months of age a single row of outer nuclei is present in the centrally located region surrounding the optic nerve head and in the most outlying region approaching the periphery, while in areas lying between these two regions, two or three rows of nuclei are seen in the outer layer
- lei are seen in the outer layer
- maximal thickness is detected on P7 compared to P11 in wild-type controls

abnormal retinal photoreceptor layer morphology
- at 9 months of age in some areas this layer is absent
- growth continues until P21 but by P28 a reduction in photoreceptor layer thickness is seen
- retarded growth of the photoreceptor layer is visible from P7 onwards

abnormal retinal photoreceptor morphology
- at 12 months of age, all visual cell structures are gone
- at 2 months of age the extreme margins of the retina lack visual cells
- at 9 months of age extensive areas of the retina completely lack visual cells

abnormal retinal pigment epithelium morphology
- at 12 months of age the pigment epithelium appears patchy with normal appearing areas adjacent to areas lacking pigment epithelial cells
- phagosomes containing debris from the outer nuclear layer are absent

abnormal retinal rod cell outer segment morphology
- the layer of rod outer segments fails to develop

absent photoreceptor outer segment
- retinal photoreceptor cells lack outer segments

absent retinal cone cells
- at 12 months of age

absent retinal rod cells
- at 12 months of age
- at 7-10 months rods are absent

decreased total retina thickness
- observed at 12 months of age

retinal degeneration
- at 12 months of age, all visual cell structures are gone and degenerative changes are observed in other layers of the retina
- at 18-24 months of age continuing degeneration results in further distortion and thinning of the retina
- at 9 months of age extensive areas of the retina completely lack visual cells
- by 28 days of age thinning of the photoreceptor and outer plexiform layers is seen
- degeneration slowly progresses until at 7-10 months rods are absent and the photoreceptor cell nuclei are reduced to 1 row
- detectable at P14 as a decrease in the thickness of the outer nuclear layer
- slight degenerative changes are seen in the outer nuclear layer starting at 5 weeks

retinal neovascularization
- extensive vascularization at 12 months of age

retinal outer nuclear layer degeneration
- degeneration of the outer nuclear cell (ONL) layer is seen as early as 2 weeks of age
- slow degeneration beginning at 5 weeks and progressing until at 7-10 months rods are absent and the photoreceptor cell nuclei are reduced to 1 row

thin retinal outer nuclear layer
- at 2 months of age thickness is reduced by about 50%
- progressive reduction in thickness of the ONL starting at P14

thin retinal outer plexiform layer
- detectable at P28 and slowly progresses with age
- thinning is more conspicuous in peripheral areas at P28

immune system phenotype

abnormal macrophage morphology
- as the outer nuclear layer thins, fewer macrophages are detected in this layer of the retina
- at 12 months of age only a few small macrophages remain in the outer aspect of the inner nuclear layer
- at P11 macrophages in the retina remain large and display high levels of glucosaminidase activity

nervous system phenotype

abnormal retinal cone cell morphology
- at 2 months of age the percentage of cones is higher in the periphery compared to wild-type controls
- the percentage of cones in the periphery further increases up until 6 months of age

abnormal retinal photoreceptor morphology
- at 12 months of age, all visual cell structures are gone
- at 2 months of age the extreme margins of the retina lack visual cells
- at 9 months of age extensive areas of the retina completely lack visual cells

abnormal retinal rod cell outer segment morphology
- the layer of rod outer segments fails to develop

absent photoreceptor outer segment
- retinal photoreceptor cells lack outer segments

absent retinal cone cells
- at 12 months of age

absent retinal rod cells
- at 12 months of age
- at 7-10 months rods are absent

Genotype: Prph2^Rd2/Prph2⁺
either: (involves: BALB/c * O20/A) or (involves: GR/A * O20/A) or (involves: O20/A * STS/A)

nervous system phenotype

abnormal photoreceptor inner segment morphology
- occasional inner segments with swollen endoplasmic reticuli and vacuoles

abnormal photoreceptor outer segment morphology
- at 18 months, outer segments become reduced and somewhat patchy
- outer segments are delayed in development but eventually appear throughout the retinal surface
- outer segments are reduced in length and morphologically abnormal appearing as round masses present from the apical end of the inner segments to the pigment epthelial villous processes
- these round masses contain irregular whorls of disc membranes that appear to be swollen and vacuolated

abnormal retinal photoreceptor morphology
- at 18 months, some photoreceptor synaptic terminals have multiple synaptic ribbons

increased retinal cone cell number
- the percentage of cones in the retina increases from 6 months on, with greater increases in the periphery than in the center of the retina

vision/eye phenotype

abnormal eye development
- at P14, considerable portions of the retinal surface have fewer outer segments and those present have disc structures that are irregularly oriented

abnormal photoreceptor inner segment morphology
- occasional inner segments with swollen endoplasmic reticuli and vacuoles

abnormal photoreceptor outer segment morphology
- at 18 months, outer segments become reduced and somewhat patchy
- outer segments are delayed in development but eventually appear throughout the retinal surface
- outer segments are reduced in length and morphologically abnormal appearing as round masses present from the apical end of the inner segments to the pigment epthelial villous processes
- these round masses contain irregular whorls of disc membranes that appear to be swollen and vacuolated

abnormal retinal layer morphology

abnormal retinal photoreceptor morphology
- at 18 months, some photoreceptor synaptic terminals have multiple synaptic ribbons

abnormal retinal pigment epithelium morphology
- peak turnover of phagosomes during the light dark cycle is shifted towards the end of the light period
- pigment epithelial cells contain larger and more numerous phagosomes

increased retinal cone cell number
- the percentage of cones in the retina increases from 6 months on, with greater increases in the periphery than in the center of the retina

thin retinal outer nuclear layer
- at 18 months, outer nuclear layer thickness is markedly decreased
- maximal outer nuclear layer thickness is only 50-60% of wild-type
- thinning of the outer nuclear layer is first seen in the peripheral retina and later seen in the central retina

pigmentation phenotype

abnormal retinal pigment epithelium morphology
- peak turnover of phagosomes during the light dark cycle is shifted towards the end of the light period
- pigment epithelial cells contain larger and more numerous phagosomes

Genotype: Prph2^Rd2/Prph2^Rd2
either: C.O20-Prph2 or C3.O20-Prph2

nervous system phenotype

abnormal Muller cell morphology
- at 2 months of age the density of Muller cells has increased dramatically, in the periphery these cells have fibers that penetrate the outer nuclear layer and cover it externally, and the number of fibrillar tangles is increased
- at 9 months of age the density of Muller cells, fibrillar tangles, and horizontal fibers in the plexiform layers is further increased
- at P11 small numbers of Muller cells and radial fibers are found in the outer plexiform layer
- at P28 the number of Muller cells is increased, the cells tend to be unevenly distributed, and occasional fibrillar tangles are seen in the inner plexiform layer

vision/eye phenotype

abnormal Muller cell morphology
- at 2 months of age the density of Muller cells has increased dramatically, in the periphery these cells have fibers that penetrate the outer nuclear layer and cover it externally, and the number of fibrillar tangles is increased
- at 9 months of age the density of Muller cells, fibrillar tangles, and horizontal fibers in the plexiform layers is further increased
- at P11 small numbers of Muller cells and radial fibers are found in the outer plexiform layer
- at P28 the number of Muller cells is increased, the cells tend to be unevenly distributed, and occasional fibrillar tangles are seen in the inner plexiform layer

thin retinal outer nuclear layer
- at 18 months, no recognizable outer nuclear layer is seen
- at 9 months, the outer nuclear layer is reduced to 2 to 3 rows

Genotype: Prph2^Rd2/Prph2⁺
either: C.O20-Prph2 or C3.O20-Prph2

nervous system phenotype

abnormal Muller cell morphology
- at 16 months, the density of Muller cells is increased compared to 2 months
- at 2 months, high numbers of Muller cells and lower numbers of fibrillar tangles and horizontal fibers are seen relative to homozygous mice

vision/eye phenotype

abnormal Muller cell morphology
- at 16 months, the density of Muller cells is increased compared to 2 months
- at 2 months, high numbers of Muller cells and lower numbers of fibrillar tangles and horizontal fibers are seen relative to homozygous mice

thin retinal outer nuclear layer
- at 16 months, the outer nuclear layer is reduced to 3 to 4 rows

Genotype: Prph2^Rd2/Prph2^Rd2
involves: BALB/c * O20/A

vision/eye phenotype

abnormal eye electrophysiology
- at 4 months, a small-amplitude b-wave is recorded

retinal degeneration
- mice exhibit 8 or 9 rows of photoreceptor nuclei at 1 months and 3 or 4 rows at 4 months

The following phenotype relates to a compound genotype created using this strain

Genotype: Prph2^Rd2/Prph2⁺
either: (involves: C3H * O20/A) or (involves: C57BL/LiA * O20/A)

nervous system phenotype

abnormal photoreceptor outer segment morphology
- Background Sensitivity - in pigmented heterozygous mice outer segments resemble those in albino mice but have more disc membranes that appear more tightly packed and less vacuolated

vision/eye phenotype

abnormal photoreceptor outer segment morphology
- Background Sensitivity - in pigmented heterozygous mice outer segments resemble those in albino mice but have more disc membranes that appear more tightly packed and less vacuolated

References

Schalken JJ; Janssen JJ; Sanyal S; Hawkins RK; de Grip WJ. 1990. Development and degeneration of retina in rds mutant mice: immunoassay of the rod visual pigment rhodopsin. Biochim Biophys Acta 1033(1):103-9PubMed: 2137350 MGI: J:109932

Additional References

Chang B; Hawes NL; Hurd RE; Davisson MT; Nusinowitz S; Heckenlively JR. 2002. Retinal degeneration mutants in the mouse. Vision Res 42(4):517-25PubMed: 11853768 MGI: J:75095

Additional - Pde6b⁺ related

Additional - Prph2^Rd2 related

Technical Support

Contact Technical Support

Genotyping Protocols
- MELT: Prph2^Rd2
- MELT: Generic Pde6b Alternate1
- Genotyping resources and troubleshooting
Mating System
- Homozygote x Homozygote
Appearance
- agouti
  Related Genotype: A/A
Citation
When using the C3A.Cg-Pde6b⁺ Prph2^Rd2/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #001979 in your Materials and Methods section.

Animal Health Reports

Facility Barrier Level Descriptions

MGL277 (Low)

Pricing & Availability

Availability Varies

Domestic
International

Live Mouse

Age

Genotype

Price

weeks

Cryorecovery - Pricing

Service	Genotype	Price
	Homozygous for Prph2<Rd2>, 1 pair minimum

We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.

Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.

Terms Of Use

Terms of Use

General Terms and Conditions

Questions about Terms of Use

Licensing Information

Phone: 207-288-6470

Email: TechTran@jax.org

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

Credit for PRODUCTS or SERVICES

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.

Animal Care and Use for SERVICES

Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.

Genetic overview

Research Applications

Base Price

Detailed Description

Development

Expression Data

Control Suggestions

Additional Information

Selected References

Prph2Rd2

Allele Symbol: Prph2Rd2

Pde6b+

Allele Symbol: Pde6b+

Disease Terms

Model with phenotypic similarity to human disease where etiologies involve orthologs. Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Genotype: Prph2Rd2 related

Genotype: Pde6b+ related

Mammalian Phenotype Terms by Genotype

Genotype: Prph2Rd2/Prph2Rd2O20/A-Prph2

cardiovascular system phenotype

pigmentation phenotype

hematopoietic system phenotype

vision/eye phenotype

immune system phenotype

nervous system phenotype

Genotype: Prph2Rd2/Prph2+either: (involves: BALB/c * O20/A) or (involves: GR/A * O20/A) or (involves: O20/A * STS/A)

nervous system phenotype

vision/eye phenotype

pigmentation phenotype

Genotype: Prph2Rd2/Prph2Rd2either: C.O20-Prph2 or C3.O20-Prph2

nervous system phenotype

vision/eye phenotype

Genotype: Prph2Rd2/Prph2+either: C.O20-Prph2 or C3.O20-Prph2

nervous system phenotype

vision/eye phenotype

Genotype: Prph2Rd2/Prph2Rd2involves: BALB/c * O20/A

vision/eye phenotype

Genotype: Prph2Rd2/Prph2+either: (involves: C3H * O20/A) or (involves: C57BL/LiA * O20/A)

nervous system phenotype

vision/eye phenotype

References

Additional References

Additional - Pde6b+ related

Additional - Prph2Rd2 related

Genotyping Protocols

Mating System

Appearance

Citation

Animal Health Reports

Live Mouse

Cryorecovery - Pricing

Payment Terms and Conditions

The Jackson Laboratory's Genotype Promise

Terms of Use

Licensing Information

JAX® Mice, Products & Services Conditions of Use

No Warranty

Credit for PRODUCTS or SERVICES

Animal Care and Use for SERVICES

No Liability

Prph2^Rd2

Allele Symbol: Prph2^Rd2

Pde6b⁺

Allele Symbol: Pde6b⁺

Genotype: Prph2^Rd2 related

Genotype: Pde6b⁺ related

Genotype: Prph2^Rd2/Prph2^Rd2
O20/A-Prph2

Genotype: Prph2^Rd2/Prph2⁺
either: (involves: BALB/c * O20/A) or (involves: GR/A * O20/A) or (involves: O20/A * STS/A)

Genotype: Prph2^Rd2/Prph2^Rd2
either: C.O20-Prph2 or C3.O20-Prph2

Genotype: Prph2^Rd2/Prph2⁺
either: C.O20-Prph2 or C3.O20-Prph2

Genotype: Prph2^Rd2/Prph2^Rd2
involves: BALB/c * O20/A

Genotype: Prph2^Rd2/Prph2⁺
either: (involves: C3H * O20/A) or (involves: C57BL/LiA * O20/A)

Additional - Pde6b⁺ related

Additional - Prph2^Rd2 related